Inhaled Budesonide May Yield Mixed Results in Premature Infants Inhaled Budesonide May Yield Mixed Results in Premature Infants

Inhaled-glucocorticoid therapy does not appear to boost the longer-term risk of neurodevelopmental disability in extremely premature infants, but might increase mortality, according to a randomized controlled trial.Reuters Health Information

Source: Medscape Medical News Headlines - January 11, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news